Status:

NOT_YET_RECRUITING

The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome

Lead Sponsor:

VA Office of Research and Development

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

* The goal of the screening trial is to determine whether early screening for atrial fibrillation improves outcomes, including lowering the chance of death, hospitalization for stroke, blood clots, he...

Detailed Description

The study hypothesis is that screening for atrial fibrillation (AF) in participants at risk for AF will be associated with a reduction in adverse cardiovascular outcomes. This trial will enroll 24,060...

Eligibility Criteria

Inclusion

  • To be eligible to participate in this study, an individual must meet all of the following criteria:
  • Male or female, age \>=65 years
  • CHA2DS2-Vasc score \>=3. The score is comprised of age (2 points for 75, 1 point for 65-74), sex (1 point for female), history of stroke, TIA, or systemic embolism (2 points), and history of heart failure, hypertension, vascular disease (including MI, peripheral artery disease, or aortic plaque), or diabetes (1 point each).

Exclusion

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Current use of anticoagulation
  • Diagnosis of AF (from administrative records or per patient during consent)
  • Cardio-thoracic surgery in the prior 3 months
  • Presence of pacemaker, implantable defibrillator, or implanted cardiac monitor
  • Clinically significant allergy to adhesives, as reported by the patient during screening for trial enrollment
  • Planned use of a brain or spinal-cord stimulator, TENS unit, or MRI scan during the period when the Zio Patch will be worn

Key Trial Info

Start Date :

June 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 3 2033

Estimated Enrollment :

24060 Patients enrolled

Trial Details

Trial ID

NCT06953778

Start Date

June 1 2026

End Date

October 3 2033

Last Update

May 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Palo Alto Health Care System, Palo Alto, CA

Palo Alto, California, United States, 94304-1207